OpenAI 2026 hackathon

Clinical Referral Copilot

Transparent, clinician-in-the-loop referral triage with evidence you can inspect.

Solo project by KP Chen · 0 likes · 0 comments

Archive position — measured, not model output

0 likes on Devpost

2,264 of the 7,856 archived projects have more likes, and 5,592 share exactly 0 — so this project's #3,312 place in the like-ranked listing is a tie-break inside that group, not a ranking.

Projects (log scale)

1
10
100
1k
10k
05,592
11,758
2285
3–4132
5–975
10+14

Likes on Devpost. ▲ marks this project's group.

Show the figures
LikesProjectsShare of archive
05,59271.2%
11,75822.4%
22853.6%
3–41321.7%
5–9751.0%
10+140.2%
Devpost like counts for all 7,856 archived projects, captured when this archive was built.

Executive Summary

The company appears to be a solo project (1 person) submitted to the OpenAI 2026 hackathon, titled Clinical Referral Copilot. The author describes it as an AI-powered tool for structuring and triaging specialist referrals in gastroenterology, with a strong emphasis on transparency, clinician control, and traceability. It is built using GPT-5.6 via the OpenAI Responses API, Next.js, TypeScript, and React.

What changed: The project is described as a demonstration of a safer pattern for healthcare AI — one that structures and explains decisions while keeping clinicians in the loop. It avoids persuasive or autonomous behavior by making uncertainty, provenance, and refusal boundaries explicit.

Single most important open question: Is there any evidence of real-world usage, clinician feedback, or integration into actual clinical workflows? The description is entirely self-reported and lacks any data on adoption, revenue, or customer engagement beyond the synthetic demo.

Back to contents

What The Product Actually Is

The description states that Clinical Referral Copilot:

  • Turns a synthetic gastroenterology referral into:
    • Structured clinical facts
    • Recommended urgency and timeframe
    • Evidence linked to exact phrases in the referral
    • Transparent synthetic rule labels
    • Missing information and uncertainty
    • Suggested pathway
    • Explicit clinician approve/edit/reject decision
  • Includes a small synthetic evaluation dashboard, safety case, identifier blocking, and narrative-free session audit trail.
  • Is built as a clean-room Next.js and TypeScript application using GPT-5.6 via the OpenAI Responses API.
  • Is explicitly synthetic-only and takes no autonomous action.

Inference: The product is a frontend UI for reviewing structured outputs from an AI model, with a focus on transparency and clinician involvement. It does not appear to be a production-ready system but rather a prototype or demo.

Back to contents

Positioning & Claim Evolution

The author states:

  • “Clinical Referral Copilot explores a safer pattern for healthcare AI: AI structures and explains; a clinician decides.”
  • The project avoids a persuasive but unsafe “AI doctor” demo by making uncertainty, provenance, refusal boundaries, and clinician authority visible.
  • It is described as a demonstration of how trust in healthcare AI can be built through inspectability, not confidence scores.

Inference: The positioning is centered on safety, transparency, and clinician control, rather than automation or efficiency. It positions itself as an alternative to traditional AI decision-making tools in healthcare.

Back to contents

Target Customer & ICP

The description states:

  • The tool is designed for clinicians reviewing specialist referrals (specifically gastroenterology).
  • It is built for rapid clinical review, with a responsive, accessible interface.
  • The user is expected to approve, edit or reject decisions made by the AI.

Inference: The ICP appears to be clinicians in specialty referral settings, particularly those dealing with high-volume, repetitive triage tasks. No evidence of other personas or use cases is provided.

Back to contents

Business Model & Pricing Evidence

The description does not state:

  • Any pricing model
  • Revenue streams
  • Customer acquisition plans
  • Monetization strategy

Not evidenced: There is no indication of a business model or pricing structure beyond the project being a hackathon submission.

Back to contents

Technical & Delivery Signals

The author states:

  • Built with: codex, gpt-5.6, json-schema, next.js, openai-responses-api, react, typescript
  • Uses GPT-5.6 via OpenAI Responses API with medium reasoning effort, store: false, and strict JSON Schema output
  • Server-side route calls the API
  • UI renders predictable structured fields
  • Allows cross-highlighting of model reasons against source phrases
  • Includes deterministic demonstration engine
  • Blocks common Singapore identifiers before processing
  • App is synthetic-only and takes no autonomous action

Inference: The technical stack suggests a frontend-heavy, AI-assisted workflow tool, with strong emphasis on structured output control and traceability. It is not a scalable or production-grade system but a prototype.

Back to contents

Traction & Maturity Signals

The description states:

  • This is a hackathon submission
  • The app is synthetic-only
  • No real-world usage, customers, or adoption data are mentioned
  • The next step is to evaluate representative synthetic cases and undergo privacy, cybersecurity, clinical-safety, and governance review

Not evidenced: There is no evidence of traction, revenue, customer engagement, or product maturity beyond a prototype.

Back to contents

Competitive Context

The description does not mention:

  • Competitors
  • Existing tools in the referral triage space
  • Market size or competitive landscape

Not evidenced: No competitive context is provided. The project appears to be self-contained and not positioned against existing solutions.

Back to contents

Key Risks & Red Flags

  • No real-world usage or feedback: The product is described as synthetic-only, with no evidence of actual clinical use.
  • Solo team: Only one person is listed on the project; no indication of a larger team or support structure.
  • Hackathon prototype: The submission is from a hackathon, suggesting it is not yet mature for production.
  • No monetization strategy: No business model or revenue plan is evident.
  • Unverified claims: All claims are self-reported and unverified.

Inference: The project is in an early stage of development and lacks any commercial or clinical traction. It may be a proof-of-concept, not a viable product for investment or partnership.

Back to contents

Diligence Questions To Ask The Founders

  1. What specific clinical workflows does this tool aim to support beyond gastroenterology?
  2. How is the synthetic data being generated, and what are the limitations of that approach?
  3. Has there been any feedback from actual clinicians on the interface or decision-making process?
  4. Are there plans to move beyond a demo into a pilot or prototype with real users?
  5. What would be the next steps in terms of clinical validation, regulatory compliance, or product development?

Back to contents

Investment/Partnership Verdict

The project is described as a hackathon submission, built by one person, and is synthetic-only. There is no evidence of revenue, customers, traction, or commercial viability.

Verdict: Not ready for investment or partnership at this stage. It is a conceptual prototype with strong safety and transparency signals but no demonstrated market or product maturity. The author states that the next step is to evaluate synthetic cases and undergo clinical-safety review — suggesting further development is needed before any real-world application.

Back to contents

Source

Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.

The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.